Perone Thomas Michael 4
4 · Ovid Therapeutics Inc. · Filed Apr 8, 2019
Insider Transaction Report
Form 4
Perone Thomas Michael
SVP, General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-04-03+125,000→ 125,000 totalExercise: $1.92Exp: 2029-03-24→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.